Pacific Biosciences of California, Inc. Available-for-sale Securities, Amortized Cost Basis
Pacific Biosciences of California, Inc. (PACB) had Available-for-sale Securities, Amortized Cost Basis of $1.08 billion as of 2021-09-30, per its 10-Q filed 2021-11-05.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecuritiesAmortizedCost · last filed 2021-11-05
- 2021-09-30: Available-for-sale Securities, Amortized Cost Basis $1.08B.
- 2021-06-30: Available-for-sale Securities, Amortized Cost Basis $1.14B.
- 2021-03-31: Available-for-sale Securities, Amortized Cost Basis $1.16B.
- 2020-12-31: Available-for-sale Securities, Amortized Cost Basis $318.73M.
| Period end | Available-for-sale Securities, Amortized Cost Basis | Available-for-sale Securities, Amortized Cost Basis as first filed |
|---|---|---|
| 2021-09-30 | $1.08B 10-Q · filed 2021-11-05 | |
| 2021-06-30 | $1.14B 10-Q · filed 2021-08-06 | |
| 2021-03-31 | $1.16B 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $318.73M 10-Q · filed 2021-11-05 | |
| 2020-09-30 | $208.43M 10-Q · filed 2020-11-03 | |
| 2020-06-30 | $119.72M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $142.56M 10-Q · filed 2020-05-08 | |
| 2019-12-31 | $49.09M 10-Q · filed 2020-11-03 | |
| 2019-09-30 | $49.19M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $66.83M 10-Q · filed 2019-08-06 | |
| 2019-03-31 | $82.87M 10-Q · filed 2019-05-03 | |
| 2018-12-31 | $102.39M 10-Q · filed 2019-11-07 | |
| 2018-09-30 | $115.77M 10-Q · filed 2018-11-05 | |
| 2018-06-30 | $63.51M 10-Q · filed 2018-08-03 | |
| 2018-03-31 | $79.30M 10-Q · filed 2018-05-02 | |
| 2017-12-31 | $62.90M 10-Q · filed 2018-11-05 | |
| 2017-09-30 | $83.97M 10-Q · filed 2017-11-02 | |
| 2017-06-30 | $102.61M 10-Q · filed 2017-08-02 | |
| 2017-03-31 | $56.05M 10-Q · filed 2017-05-05 | |
| 2016-12-31 | $71.97M 10-K · filed 2018-02-26 | |
| 2016-09-30 | $87.31M 10-Q · filed 2016-11-04 | |
| 2016-06-30 | $102.42M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $91.49M 10-Q · filed 2016-05-05 | |
| 2015-12-31 | $82.28M 10-K · filed 2017-03-06 | |
| 2015-09-30 | $58.90M 10-Q · filed 2015-11-05 | |
| 2015-06-30 | $72.66M 10-Q · filed 2015-08-05 | |
| 2015-03-31 | $79.13M 10-Q · filed 2015-05-05 | |
| 2014-12-31 | $101.34M 10-K · filed 2016-03-11 | |
| 2014-09-30 | $99.29M 10-Q · filed 2014-11-05 | |
| 2014-06-30 | $104.99M 10-Q · filed 2014-08-05 | |
| 2014-03-31 | $118.72M 10-Q · filed 2014-05-08 | |
| 2013-12-31 | $112.51M 10-Q · filed 2014-11-05 | |
| 2013-09-30 | $126.92M 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $106.97M 10-Q · filed 2013-08-09 | |
| 2013-03-31 | $112.30M 10-Q · filed 2013-05-10 | |
| 2012-12-31 | $100.55M 10-K · filed 2014-03-14 | |
| 2012-09-30 | $32.56M 10-Q · filed 2012-11-01 | |
| 2012-06-30 | $33.62M 10-Q · filed 2012-08-07 | |
| 2011-12-31 | $177.38M 10-K · filed 2013-03-15 | $58.87M 10-Q · filed 2012-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |